Markel Group Inc. (MKL)

NYSE • Currently up 35.06 (+1.89%) in today's trading session

4 members of Congress have disclosed 20 trades in Markel Group Inc. (MKL) via STOCK Act filings. The most recent disclosure was a purchase by April McClain Delaney on 30 April 2026. The most active traders have been April McClain Delaney (16), Thomas H. Kean Jr (2), and Thomas H. Kean (1). Aggregate disclosed activity totals roughly $201.5K in purchases and $81K in sales (midpoint estimates from bracketed disclosure amounts).

Markel Group Inc. is currently trading at $1893.97, positioned at 36% of its 52-week range ($1719.41 – $2207.59).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$1893.97
24h Change
+35.06 (+1.89%)
52 Week Range
$1719.41—$2207.59
View on NASDAQ

Markel Group Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for MKL

Select to highlight on chart
19 transactions
Compliance: 95%
April McClain Delaney30 Apr 20266 May 2026PurchaseStock$1,001 - $15,000+7.66%
Thomas H. Kean Jr23 Jan 202619 Feb 2026SaleStock$15,001 - $50,000N/A
April McClain Delaney3 Nov 20258 Dec 2025PurchaseStock$1,001 - $15,000-3.13%
Thomas H. Kean Jr12 Sept 202514 Oct 2025SaleStock$15,001 - $50,000N/A
April McClain Delaney21 Aug 20252 Sept 2025PurchaseStock$15,001 - $50,000-3.95%
April McClain Delaney7 Aug 20252 Sept 2025PurchaseStock$1,001 - $15,000-3.16%
April McClain Delaney1 Aug 20252 Sept 2025PurchaseStock$15,001 - $50,000-5.69%
April McClain Delaney25 Jul 20255 Aug 2025PurchaseStock$1,001 - $15,000-5.46%
April McClain Delaney9 Jul 20255 Aug 2025PurchaseStock$1,001 - $15,000-5.18%
April McClain Delaney6 Jun 20252 Jul 2025PurchaseStock$1,001 - $15,000N/A
April McClain Delaney27 May 20252 Jun 2025PurchaseStock$1,001 - $15,000N/A
April McClain Delaney13 May 20252 Jun 2025PurchaseStock$1,001 - $15,000N/A
April McClain Delaney7 May 20252 Jun 2025PurchaseStock$1,001 - $15,000N/A
April McClain Delaney24 Apr 20252 May 2025PurchaseStock$1,001 - $15,000N/A
April McClain Delaney9 Apr 20252 May 2025PurchaseStock$1,001 - $15,000N/A
April McClain Delaney10 Mar 20252 Apr 2025PurchaseStock$1,001 - $15,000N/A
April McClain Delaney7 Mar 20252 Apr 2025PurchaseStock$15,001 - $50,000N/A
April McClain Delaney6 Mar 20252 Apr 2025PurchaseStock$1,001 - $15,000N/A
Thomas H. Kean10 Jan 202311 Feb 2023SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$23.7B

Volume

35.31K

Beta

0.67

P/E Ratio

16.85

Fundamentals

EPS

$112.42

Div. Yield

—

Open

$1869.81

Day Range

$1860.00 — $1896.13

Company Information

Sector
Financial Services
Industry
Insurance - Property & Casualty
Exchange
NYSE · USD
Country
US
CEO
Thomas Sinnickson Gayner
IPO Date
1986-12-12
Website
www.markel.com

Markel Corporation operates as a multifaceted financial conglomerate, engaging in the marketing and underwriting of specialized insurance offerings across numerous global regions. Its operational footprint spans the United States, Bermuda, the United...

Earnings

Next Report

Q2 2026

29 Jul

EPS Est.

$29.24

Rev. Est.

$4.5B

Days Until

35

Recent Quarters

Q1 202628 Apr
EPS$21.61
Miss 18.1%
Q4 20254 Feb
EPS$34.45
Beat 24.7%
Q3 202529 Oct
EPS$30.90
Beat 28.6%
Q2 202530 Jul
EPS$25.46
Beat 2.0%
Q1 202530 Apr
EPS$25.72
Beat 53.4%
Q4 20245 Feb
EPS$20.51
Beat 8.0%
Q3 202430 Oct
EPS$17.34
Miss 19.1%
Q2 202431 Jul
EPS$25.95
Beat 16.4%
Q1 20241 May
EPS$18.17
Beat 1.3%
Q4 202331 Jan
EPS$56.48
Beat 139.5%
Q3 20231 Nov
EPS$16.56
Miss 21.1%
Q2 20232 Aug
EPS$22.43
Beat 17.0%
Q1 202326 Apr
EPS$17.35
Beat 6.9%
Q4 20221 Feb
EPS$26.15
Beat 41.6%
Q3 20221 Nov
EPS$13.17
Miss 25.4%
Q2 20222 Aug
EPS$13.78
Miss 35.7%
Q1 202226 Apr
EPS$11.33
Miss 32.5%
Q4 20212 Feb
EPS$15.71
Miss 5.0%
Q3 20212 Nov
EPS$16.54
Beat 39.7%
Q2 20213 Aug
EPS$19.14
Beat 23.9%
Q1 202128 Apr
EPS$10.12
Miss 11.0%
Q4 20202 Feb
EPS$15.83
Beat 75.1%
Q3 202027 Oct
EPS$4.41
Beat 444.4%
Q2 202028 Jul
EPS$14.89
Beat 71.2%
Q1 202028 Apr
EPS$-8.92
Miss 195.5%
Q4 20194 Feb
EPS$6.57
Miss 7.1%
Q3 201929 Oct
EPS$10.31
Beat 35.0%
Q2 201930 Jul
EPS$11.84
Beat 16.6%
Q1 201930 Apr
EPS$9.24
Miss 1.8%
Q4 20185 Feb
EPS$2.27
Miss 31.4%
Q3 201830 Oct
EPS$28.50
Beat 304.3%
Q2 201831 Jul
EPS$19.97
Beat 135.2%
Q1 201824 Apr
EPS$11.39
Beat 30.8%
Q4 20176 Feb
EPS$6.64
Miss 22.3%
Q3 201725 Oct
EPS$-16.66
Miss 3.0%
Q2 201726 Jul
EPS$10.29
Beat 56.6%
Q1 201726 Apr
EPS$3.24
Miss 28.0%
Q4 20168 Feb
EPS$9.14
Beat 74.8%
Q3 20161 Nov
EPS$4.00
Miss 47.7%
Q2 20162 Aug
EPS$6.73
Beat 5.3%
Q1 20163 May
EPS$9.89
Beat 45.7%
Q4 201510 Feb
EPS$14.14
Beat 109.2%
Q3 20154 Nov
EPS$8.00
Beat 27.8%
Q2 20155 Aug
EPS$6.32
Beat 0.6%
Q1 20156 May
EPS$13.16
Beat 123.8%
Q4 201411 Feb
EPS$7.18
Beat 26.0%
Q3 20145 Nov
EPS$5.17
Miss 3.7%
Q2 20146 Aug
EPS$2.66
Miss 54.1%
Q1 20147 May
EPS$6.25
Beat 9.3%
Q4 201310 Feb
EPS$6.95
Beat 21.9%
Q3 20136 Nov
EPS$4.67
Miss 23.3%
Q2 20137 Aug
EPS$5.76
Beat 5.7%
Q1 201330 Apr
EPS$8.09
Beat 50.6%
Q4 20124 Feb
EPS$5.66
Beat 307.3%
Q3 20128 Nov
EPS$4.96
Beat 12.0%
Q2 20128 Aug
EPS$7.87
Beat 121.7%
Q1 20129 May
EPS$4.97
Beat 26.5%
Q4 20111 Feb
EPS$4.44
Beat 2.5%
Q3 20117 Nov
EPS$4.62
Beat 17.6%
Q2 20118 Aug
EPS$3.02
Miss 22.2%
Q1 20115 May
EPS$0.10
Miss 94.9%
Q4 20102 Feb
EPS$12.91
Beat 194.8%
Q3 20105 Nov
EPS$5.86
Beat 63.7%
Q2 20106 Aug
EPS$2.29
Miss 41.9%
Q1 20105 May
EPS$3.29
Miss 28.9%
Q4 20093 Feb
EPS$9.05
Beat 88.9%
Q3 20094 Nov
EPS$7.98
Beat 77.3%
Q2 20095 Aug
EPS$4.36
Miss 14.0%
Q1 20096 May
EPS$5.32
Miss 5.0%
Q4 20082 Feb
EPS$10.38
Beat 79.3%
Q3 20084 Nov
EPS$-3.32
Miss 1609.1%
Q2 20084 Aug
EPS$6.67
Miss 5.1%
Q1 200830 Apr
EPS$7.08
Miss 7.8%
Q4 200724 Jan
EPS$9.70
Beat 12.4%
Q3 200731 Oct
EPS$9.06
Beat 9.9%
Q2 200731 Jul
EPS$8.79
Beat 2.1%
Q1 20071 May
EPS$9.22
Beat 12.2%
Q4 200624 Jan
EPS$10.62
Beat 25.5%
Q3 200631 Oct
EPS$10.38
Beat 55.9%
Q2 20061 Aug
EPS$8.60
Beat 23.6%
Q1 20062 May
EPS$5.69
Miss 13.0%
Q4 200525 Jan
EPS$12.21
Beat 262.3%
Q3 20052 Nov
EPS$-11.82
Miss 28.2%
Q2 20052 Aug
EPS$5.82
Miss 7.3%
Q1 20053 May
EPS$6.36
Beat 10.6%
Q4 200426 Jan
EPS$5.15
Miss 15.2%
Q3 200427 Oct
EPS$1.00
Beat 426.3%
Q2 200428 Jul
EPS$6.00
Beat 19.3%
Q1 200428 Apr
EPS$3.80
Miss 17.9%
Q4 200315 Mar
EPS$4.54
Q3 200328 Oct
EPS$-1.19
Beat 38.0%
Q2 200329 Jul
EPS$3.55
Beat 5.0%
Q1 200329 Apr
EPS$3.27
Beat 28.7%
Q4 200226 Mar
EPS$2.68
Q3 200230 Oct
EPS$-0.83
Miss 141.5%
Q2 200231 Jul
EPS$1.60
Miss 20.4%
Q1 20021 May
EPS$1.36
Miss 30.3%
Q4 200127 Mar
EPS$-4.47
Q3 200131 Oct
EPS$-11.22
Miss 149.9%
Q2 20011 Aug
EPS$0.29
Miss 74.6%
Q2 20011 Aug
EPS$0.29
Miss 74.6%
Q1 20012 May
EPS$0.19
Miss 79.8%
Q3 20001 Nov
EPS$-2.15
Miss 732.4%
Q2 20007 Aug
EPS$-1.57
Miss 194.6%
Q1 20003 May
EPS$2.08
Miss 4.2%
Q4 199917 Mar
EPS$0.93
Q3 199927 Oct
EPS$1.77
Miss 20.3%
Q2 199928 Jul
EPS$2.10
Beat 0.0%
Q1 199928 Apr
EPS$2.00
Beat 3.6%
Q4 19983 Feb
EPS$2.12
Beat 6.5%
Q3 199827 Oct
EPS$2.14
Beat 8.1%
Q2 199828 Jul
EPS$2.71
Beat 39.0%
Q1 199829 Apr
EPS$1.96
Beat 2.1%
Q4 19974 Feb
EPS$2.02
Beat 9.8%
Q3 199727 Oct
EPS$1.95
Beat 12.7%
Q2 199729 Jul
EPS$1.72
Beat 0.6%
Q1 199729 Apr
EPS$1.71
Beat 4.3%
Q4 19965 Feb
EPS$1.96
Beat 25.6%
Q3 199628 Oct
EPS$1.50
Miss 3.2%
Q2 199630 Jul
EPS$1.36
Miss 1.4%
Q1 199630 Apr
EPS$1.04
Miss 23.0%
Q4 19958 Feb
EPS$1.38
Beat 15.0%
Q3 199530 Oct
EPS$1.59
Beat 47.2%
Q2 199531 Jul
EPS$1.14
Beat 11.8%
Q1 199528 Apr
EPS$1.17
Beat 18.2%
Q4 19948 Feb
EPS$0.82
Beat 6.5%
Q3 19941 Nov
EPS$0.76
Beat 7.0%
Q2 19942 Aug
EPS$0.72
Beat 1.4%
Q1 19943 May
EPS$0.93
Beat 47.6%
Q4 199316 Feb
EPS$0.67
Beat 11.7%
Q3 19935 Nov
EPS$1.01
Beat 46.4%
Q2 19933 Aug
EPS$0.56
Miss 21.1%
Q1 199311 May
EPS$1.02
Beat 29.1%
Q4 199216 Feb
EPS$0.67
Beat 36.7%
Q2 199230 Sept
EPS$0.73
Q1 199230 Jun
EPS$0.88
Q4 199131 Mar
EPS$2.27
Q3 199131 Dec
EPS$0.65
Q2 199130 Sept
EPS$0.61
Q1 199130 Jun
EPS$0.59
Q4 199031 Mar
EPS$0.83
Q3 199031 Dec
EPS$-0.53
Q2 199030 Sept
EPS$0.59
Q1 199030 Jun
EPS$0.50
Q4 198931 Mar
EPS$0.50
Q3 198931 Dec
EPS$0.81
Q2 198930 Sept
EPS$0.73
Q1 198930 Jun
EPS$0.60
Q4 198831 Mar
EPS$0.50
Q3 198831 Dec
EPS$0.64
Q2 198830 Sept
EPS$0.58
Q1 198830 Jun
EPS$0.54
Q4 198731 Mar
EPS$0.52
Q3 198731 Dec
EPS$0.29
Q2 198730 Sept
EPS$0.34
Q1 198730 Jun
EPS$0.45
Q4 198631 Mar
EPS$0.33
Q3 198631 Dec
EPS$0.32
Q2 198630 Sept
EPS$0.32
Q1 198630 Jun
EPS$0.32
Q4 198531 Mar
EPS$0.32
Q3 198531 Dec
EPS$0.09
Q2 198530 Sept
EPS$0.06

7 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

11 Sept 1989Stock Split
Ratio6:5

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about MKL

Which members of Congress have traded MKL?
4 members of Congress have disclosed 20 trades in Markel Group Inc. (MKL) under the STOCK Act. The most active traders are April McClain Delaney, Thomas H. Kean Jr, and Thomas H. Kean.
When was MKL most recently disclosed by Congress?
The most recent MKL disclosure was a purchase by April McClain Delaney on 30 April 2026.
What is the total disclosed congressional trading volume for MKL?
Members of Congress have disclosed approximately $201.5K in MKL purchases and $81K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in MKL?
This MKL page updates as soon as new STOCK Act disclosures are filed for Markel Group Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.